EUDA Health Holdings Limited (EUDA)
NASDAQ: EUDA · Real-Time Price · USD
0.735
-0.052 (-6.64%)
Mar 5, 2026, 4:00 PM EST - Market closed
Company Description
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.
It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements.
The company also provides property management services. The company is headquartered in Singapore.
EUDA Health Holdings Limited
| Country | Singapore |
| Founded | 2021 |
| Industry | Real Estate Services |
| Sector | Real Estate |
| Employees | 117 |
| CEO | Alfred Lim |
Contact Details
Address: 60 Kaki Bukit Place, No. 03-01 Eunos Techpark Singapore, 415979 Singapore | |
| Phone | 65 6327 1110 |
| Website | eudahealth.com |
Stock Details
| Ticker Symbol | EUDA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001847846 |
| CUSIP Number | G3142E105 |
| ISIN Number | VGG3142E1051 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Alex Lai | Chief Executive Officer of CK Health Plus |
| Alfred Lim | Chief Executive Officer and Executive Director |
| Daniel Tan | Chief Technology Officer |
| Whye Shin Tay | Interim Chief Financial Officer |
| Aaron Lim | Operational Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 5, 2026 | 6-K | Report of foreign issuer |
| Mar 2, 2026 | 6-K | Report of foreign issuer |
| Mar 2, 2026 | 424B5 | Filing |
| Jan 23, 2026 | 424B5 | Filing |
| Jan 15, 2026 | 6-K | Report of foreign issuer |
| Jan 13, 2026 | 424B5 | Filing |
| Jan 13, 2026 | 6-K | Report of foreign issuer |
| Jan 13, 2026 | 6-K | Report of foreign issuer |
| Jan 7, 2026 | 6-K | Report of foreign issuer |
| Dec 30, 2025 | 6-K | Report of foreign issuer |